This interview analysis is sponsored by AcuityMD and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

The MedTech commercial sector in 2026 is defined by a paradox of data. While research and development complexity has surged, commercial operations often remain anchored to unpredictable market variables and manual knowledge transfer. This friction is compounded by a disarray of disjointed tools — disparate CRMs, spreadsheets, and manual notes — that obscure visibility for leadership and burden field representatives.

These operational bottlenecks occur against a backdrop of rapid structural shifts in the healthcare environment. According to the Centers for Medicare & Medicaid Services, the migration of high-acuity procedures to Ambulatory Surgery Centers (ASCs) continues to accelerate, with cardiac and orthopedic volumes shifting significantly away from traditional hospital settings.

Compounding this is a volatile talent market. Research from Bain & Company indicates that commercial rep turnover in highly competitive therapeutic areas remains a primary headwind for growth. Industry benchmarks suggest the ramp time to full productivity for a new hire can span six to nine months, representing a substantial loss in unrealized pipeline.

Emerj recently hosted a conversation with AcuityMD leadership on the ‘AI in Business’ podcast, including Chief Executive Officer Michael Monovoukas and Chief Revenue Officer Alex Wakefield, to analyze how AI-driven intelligence is being used to dismantle sales inertia in the Medtech space.

This article examines the strategic pillars required to modernize MedTech commercial workflows:

• Predictive Market Intelligence Replaces Reactive CRM Reporting: Integrating external market signals and field‑level insights to give leaders real‑time visibility into shifting commercial conditions.
• Voice‑First Workflows Eliminate Administrative Drag: Transforming drive time and transition time into structured field intelligence through AI‑driven voice capture.
• Contextual AI Elevates Representative Effectiveness: Delivering territory‑specific, account‑specific, and moment‑specific guidance that improves field performance and accelerates revenue impact.
• Revenue‑Centric ROI Redefines AI Value in MedTech: Measuring success through increased rep effectiveness and market responsiveness rather than labor substitution.

Episode: Turning Market Shifts into Field Action for Medtech Commercial Teams – with Mike Monovoukas & Alex Wakefield of AcuityMD

Guest: Michael Monovoukas, CEO & Co-founder at AcuityMD​

Expertise: MedTech Entrepreneurship, AI-Driven Analytics, Commercial Strategy, SaaS Innovation, Healthcare Data Infrastructure, Adaptive Go-to-Market​

Brief Recognition: Michael Monovoukas is the CEO and Co-founder of AcuityMD, where he leads a data-driven commercial platform recently named to Forbes’ 2025 “Next Billion-Dollar Startups” list. A former management consultant at Bain & Company and leader at PatientPing, he has focused his career on modernizing MedTech commercialization through AI and advanced analytics. Michael holds an MBA from Harvard Business School and a B.A. in Public Policy and Finance from Princeton University.​

Guest: Alex Wakefield, Chief Retention Officer at AcuityMD​

Expertise: Revenue Acceleration, Commercial Operations, Supply Chain Logistics, , Sales Leadership, M&A & Growth Strategy, Working Capital Optimization​

Brief Recognition: Alex Wakefield is the Chief Revenue Officer at AcuityMD, bringing over 25 years of leadership in sales, supply chain, and commercial operations to the MedTech sector. He previously served as CEO of Longbow Advantage, where he tripled the company’s size, and held senior executive roles at Model N and Blue Yonder. A former U.S. Navy Supply Corps Officer, Alex holds an MBA from Rensselaer Polytechnic Institute and a B.A. in Economics from Vanderbilt University.

​

Predictive Market Intelligence Replaces Reactive CRM Reporting

Traditional CRM systems in MedTech are fundamentally limited by their reliance on manual data entry. Monovoukas characterizes these systems as focused primarily on historical questions regarding past activities: “What did you do?” or “Did you visit this account?”. While these tools store massive amounts of data, they often offer zero visibility into the real-time market signals that dictate future sales success.

For a commercial strategy to be proactive, it must integrate two distinct types of data flows:

Field‑based signals: Real‑time observations from ORs (Operating Rooms) and hospitals, which rarely enter systems because static forms and spreadsheets don’t match the fluid nature of fieldwork

External market signals: Physician retirements, ASC (Ambulatory Surgery Centers) migration, shifting referral networks, which directly shape next‑best actions but remain scattered across disconnected sources.

“By nature, those systems, even though they store a lot of data, when compliance is high, they’re looking in the rear view mirror about what’s happened, and they only given the lens of the rep or the company, and that misses all of this market signal about what’s actually happening in the market to help these companies and these selling organizations be proactive or learning about how to adapt to a changing landscape.”

— Michael Monovoukas, CEO & Co-founder, AcuityMD

​

Voice‑First Workflows Eliminate Administrative Drag

The MedTech commercial industry has historically been a late adopter of technology, largely because the role of a field representative is intensely interpersonal. Many representatives prioritize clinical support and surgeon relationships over technology use, often viewing software as a secondary administrative burden. Wakefield notes that even in successful organizations, representatives may still rely on manual notes or even lack issued laptops entirely.

The administrative burden on field workers and the sector at large is significant. According to a 2025 analysis published in the National Library of Medicine, approximately $1 trillion — or 20% to 25% of all healthcare dollars — is spent annually on administrative services in the United States.

In the field however, processes are more manual, and administration often manifests as representatives taking matters into their own hands, often paying out of pocket for consumer AI tools to plan calls because enterprise systems are too cumbersome. To bridge this gap, AI must meet the representative where they are rather than forcing them into a traditional user interface.

Instead of requiring a representative to log in to a system at night, AI-driven voice collection enables audible interaction during transition periods, such as drives between clinics. This approach allows representatives to consume data about a facility’s procedure volume and then dictate field signals back into the system instantaneously.

“The key is meeting the sales rep and process where they are… you can sort of dispel the notion of, logging into a system or UI or user interface. When you think about voice collection or voice dictation… a rep in the car can audibly interact with their phone, get all the information they need, and then voice dictate data collection back into the system.”

— Alex Wakefield, CRO, AcuityMD

This leapfrog effect is critical for organizations that have struggled with CRM discipline. By moving directly from manual processes to voice-enabled AI, companies can achieve higher-fidelity documentation than was possible with traditional software. Michael Monovoukas suggests that a 15-minute context-sharing session via AI can provide more depth than scouring months of static CRM notes.

​

Contextual AI Elevates Representative Effectiveness:

Automating administrative work is a baseline requirement, but the true value of AI in the commercial arena lies in its ability to generate proactive and predictive insights. Monovoukas argues that AI must show representatives what they don’t know, acting as a strategic partner that suggests which physician to call on and what specific clinical context to bring into the conversation.

A common failure in enterprise AI adoption is the disconnect between purchased tools and the value they deliver. To move past this, organizations must infuse AI models with specific layers of context:

• Market Context: Specific clinical and data signals governing the medical device domain.
• User Context: The representative’s specific territory, sales goals, and tenure.
• Organizational Context: The company’s broader enterprise strategy and market positioning.

When these layers are integrated, the AI can provide situational nudges. For example, if a surgery is canceled at 2:00 PM, the system can immediately identify nearby prospecting opportunities based on real-time referral patterns. This prevents dead time in the representative’s schedule and ensures they are always focused on the highest-probability targets.

​

Revenue‑Centric ROI Redefines AI Value in MedTech:

Commercial leaders often view AI through the lens of labor replacement, yet in MedTech, this framing is inaccurate. The visceral nature of surgical training and OR support means that representatives remain indispensable — both Wakefield and Monovoukas argue that ROI must therefore be measured through two specific metrics: rep effectiveness and rep efficiency.

Effectiveness measures how well a representative presents as a subject-matter expert to a surgeon. AI drives this by synthesizing complex data, such as a hospital’s economic position or a competitor’s clinical gaps, into a format the representative can use during a pitch. According to Alex, efficiency focuses on 10x gains by automating the research traditionally done on LinkedIn, PubMed, or Google.

Wakefield emphasizes that realizing this value depends on open-mindedness within the field team. While new representatives often embrace these tools to learn their territories faster, seasoned representatives must also be willing to challenge their existing assumptions about their networks.

Ultimately, this shift requires leadership to lead from the front. Monovoukas emphasizes the need for leadership buy-in to drive organizational transformation. When executives demonstrate how technology has transformed their own ability to operate the business, it creates the organizational trust necessary for large-scale commercial change.